Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Roger David Klein"'
Autor:
Sarabjot Pabla, Robert J. Seager, Mary Nesline, Paul DePietro, Erik Van Roey, Shuang Gao, Shakti Ramkissoon, Lei Deng, Shengle Zhang, Roger David Klein, Jeffrey M. Conroy
Publikováno v:
Journal of Clinical Oncology. 40:2623-2623
2623 Background: Immune checkpoint inhibitors (ICIs) have emerged as effective treatments in non-small cell lung cancer (NSCLC). While the clinical utility of single agent ICI or in combination with chemotherapy has been well established, there remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::260bc4a948f61a48c4d9a40996590575
https://doi.org/10.1200/jco.2022.40.16_suppl.2623
https://doi.org/10.1200/jco.2022.40.16_suppl.2623
Autor:
Mary Nesline, Sarabjot Pabla, Yong Hee Lee, Paul DePietro, Shengle Zhang, Roger David Klein, Jeffrey M. Conroy, Shakti Ramkissoon, Amy P. Early, Lei Deng, Grace K. Dy
Publikováno v:
Journal of Clinical Oncology. 40:e21167-e21167
e21167 Background: CGIP analyzes FFPE tumor tissue by DNA/RNA sequencing for SNVs, indels, copy gain/loss, fusions, splice variants, MSI and TMB, along with PD-L1 IHC. A purported advantage of CGIP in NSCLC is the ability to identify targeted and imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ea961b29d17a3ac6f06a4448ba01515
https://doi.org/10.1200/jco.2022.40.16_suppl.e21167
https://doi.org/10.1200/jco.2022.40.16_suppl.e21167